Account Info
Log Out
English
Back
Log in to access Online Inquiry
Watchlist
Loading...
US Stock MarketDetailed Quotes
RAIN Rain Oncology Watchlist
8.720 +0.270+3.20% Close 03/29 16:00 ET
8.7200.0000.00% Post 16:00 ET
9.065High8.520Low96.24KVolume
Quarterly+Annual
YOY
Hide blank lines
(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30(Q2)2021/06/30(Q1)2021/03/31
Total revenue
0000000000
Operating revenue
--0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense
49.74%77.14M30.31%23.56M-0.15%18.41M116.36%17.72M156.32%17.45M171.72%51.51M231.57%18.08M117.33%18.44M215.93%8.19M180.16%6.81M
Selling and administrative expenses
46.53%15.74M31.54%4.48M23.68%3.9M28.19%3.46M163.18%3.9M199.05%10.74M166.02%3.41M433.67%3.15M141.29%2.7M121.56%1.48M
-General and administrative expense
46.53%15.74M31.54%4.48M23.68%3.9M28.19%3.46M163.18%3.9M199.05%10.74M166.02%3.41M433.67%3.15M141.29%2.7M121.56%1.48M
Research and development costs
50.59%61.4M30.03%19.08M-5.06%14.51M159.74%14.26M154.41%13.56M165.33%40.77M251.68%14.67M93.64%15.28M272.64%5.49M202.38%5.33M
Operating profit
-49.74%-77.14M-30.31%-23.56M0.15%-18.41M-116.36%-17.72M-156.32%-17.45M-171.72%-51.51M-231.57%-18.08M-117.33%-18.44M-215.93%-8.19M-180.16%-6.81M
Net non-operating interest income expense
1,079.17%1.42M828.42%882K3,263.64%370K1,683.33%107K600.00%56K216.50%120K955.56%95K115.49%11K122.22%6K172.73%8K
Non-operating interest income
1,079.17%1.42M828.42%882K3,263.64%370K1,683.33%107K600.00%56K275.00%120K955.56%95K--11K0.00%6K-60.00%8K
Non-operating interest expense
----------------------------------0----
Other net income (expense)
100.05%1K
Other non- operating income (expenses)
----------------------------100.05%1K--------
Income before tax
-47.34%-75.72M-26.09%-22.68M2.09%-18.04M-115.21%-17.61M-155.79%-17.39M-143.76%-51.39M-230.39%-17.98M-76.39%-18.43M-211.85%-8.18M-164.69%-6.8M
Income tax
50.00%3K2K
Net income
-47.34%-75.72M-26.09%-22.68M2.09%-18.04M-115.21%-17.61M-155.79%-17.39M-143.77%-51.39M-230.42%-17.99M-76.39%-18.43M-211.85%-8.18M-164.69%-6.8M
Net income continuous Operations
-47.34%-75.72M-26.09%-22.68M2.09%-18.04M-115.21%-17.61M-155.79%-17.39M-143.77%-51.39M-230.42%-17.99M-76.39%-18.43M-211.85%-8.18M-164.69%-6.8M
Minority interest income
Net income attributable to the parent company
-47.34%-75.72M-26.09%-22.68M2.09%-18.04M-115.21%-17.61M-155.79%-17.39M-143.77%-51.39M-230.42%-17.99M-76.39%-18.43M-211.85%-8.18M-164.69%-6.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-47.34%-75.72M-26.09%-22.68M2.09%-18.04M-115.21%-17.61M-155.79%-17.39M-143.77%-51.39M-230.42%-17.99M-76.39%-18.43M-211.85%-8.18M-164.69%-6.8M
Basic earnings per share
-2.26%-2.71-2.94%-0.72.86%-0.68-69.23%-0.66-152.05%-0.66-33.95%-2.65-33.14%-0.6828.59%-0.7-58.39%-0.39-8.62%-0.2618
Diluted earnings per share
-2.26%-2.71-2.94%-0.72.86%-0.68-69.23%-0.66-152.05%-0.66-33.95%-2.65-33.14%-0.6828.59%-0.7-58.39%-0.39-8.62%-0.2618
Dividend per share
Currency Unit
USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion--------Unqualified Opinion--------
Paper Trade More
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--